The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods

Area of Science:

• Child and Adolescent Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Obsessive-compulsive disorder (OCD) affects 1 in 200 children and adolescents, causing significant functional impairment.
• Selective serotonin reuptake inhibitors (SSRIs) and cognitive-behavior therapy (CBT) show efficacy, but partial response and treatment durability vary.
• Understanding optimal treatment strategies for pediatric OCD is crucial.

Purpose of the Study:

• To evaluate the relative benefits and durability of sertraline, CBT, combination therapy, and placebo in children and adolescents with OCD.
• To compare short-term efficacy and long-term outcomes of different treatment modalities.
• To inform clinical practice for pediatric OCD management.

Main Methods:

• A multicenter, randomized, masked clinical trial involving 120 subjects aged 7-17 with OCD.
• Stage 1: 12-week randomized comparison of sertraline, CBT, combination, and placebo.
• Stage 2: Open follow-up for responders, with tailored open-label treatment for non-responders or relapsed patients.

Main Results:

• The study design allows for a rigorous comparison of four distinct treatment arms.
• It investigates both immediate treatment response and the durability of effects after treatment discontinuation.
• Data will elucidate differential outcomes between medication, therapy, and combination approaches.

Conclusions:

• The Pediatric OCD Treatment Study provides a robust design to compare leading treatments for pediatric OCD.
• Findings will clarify the comparative effectiveness and long-term utility of sertraline, CBT, and their combination.
• This research aims to optimize treatment selection for improved patient outcomes.